Warning letter
Effingham Equity: warning letter of Sep 20, 2022
FDA warning letter 628068 · Division of Human and Animal Food Operations East VI
Key facts
| Reference number | 628068 |
|---|---|
| Company | Effingham Equity |
| Subject | CGMP/Medicated Feeds/Adulterated |
| Issue date | Sep 20, 2022 |
| Posted date | Nov 22, 2022 |
| Issuing office | Division of Human and Animal Food Operations East VI |
| Product type | Veterinary |
| CFR sections cited | 225.42(b)(4), 225, 507, 507.33(c)(1), 507.1(a)(1)(ii), 507.33(a)(1) |
| Inspection city | Effingham |
| Inspection ZIP | 62401 |
| Inspection start date | Dec 13, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: